BACKGROUND AND PURPOSE: Diabetes mellitus (DM) is a major stroke risk factor and is associated with poor recovery compared with nondiabetic stroke patients. In the present study, we investigated the effects of tissue plasminogen activator (tPA) treatment of stroke in diabetic and non-diabetic rats. METHODS: Type-1 diabetes (T1DM) was induced by injection of streptozotocin. Non-T1DM and T1DM rats were subjected to embolic middle cerebral artery occlusion (MCAo) and treated with or without tPA 2h after MCAo. Functional outcomes and immunostaining for advanced glycation endproducts receptor (RAGE), matrix metalloproteinase-9 (MMP-9) and toll-like receptor 4 (TLR4) and Western blotting were performed. RESULTS: tPA treatment of WT-MCAo rats significantly improved the functional outcome and reduced the lesion volume compared with non-treatment WT-MCAo rats (p<0.05). There was no significant difference between treatment with or without tPA in the WT-MCAo group in brain hemorrhage, BBB leakage and expression of inflammatory mediators, RAGE, MMP-9 and TLR4. However, tPA treatment in T1DM-MCAo rats (T1DM-MCAo+tPA) significantly enlarged brain hemorrhage, augmented BBB leakage, and failed to decrease lesion volume and improve functional outcome after stroke compared to T1DM-MCAo control. tPA treatment also significantly increased the expression of RAGE, MMP-9 and TLR4 in the ischemic brain in T1DM-MCAo rats compared with T1DM-MCAo control rats (p<0.05). Brain hemorrhage was significantly correlated with functional deficit and RAGE and TLR4 expression, respectively. CONCLUSIONS: Treatment of stroke with tPA increased brain hemorrhage, BBB leakage and failed to improve functional outcome in T1DM rats. The increased inflammatory response may contribute to the failed neuroprotective effects of tPA treatment in T1DM rats.
BACKGROUND AND PURPOSE:Diabetes mellitus (DM) is a major stroke risk factor and is associated with poor recovery compared with nondiabetic strokepatients. In the present study, we investigated the effects of tissue plasminogen activator (tPA) treatment of stroke in diabetic and non-diabeticrats. METHODS:Type-1 diabetes (T1DM) was induced by injection of streptozotocin. Non-T1DM and T1DM rats were subjected to embolic middle cerebral artery occlusion (MCAo) and treated with or without tPA2h after MCAo. Functional outcomes and immunostaining for advanced glycation endproducts receptor (RAGE), matrix metalloproteinase-9 (MMP-9) and toll-like receptor 4 (TLR4) and Western blotting were performed. RESULTS:tPA treatment of WT-MCAo rats significantly improved the functional outcome and reduced the lesion volume compared with non-treatment WT-MCAo rats (p<0.05). There was no significant difference between treatment with or without tPA in the WT-MCAo group in brain hemorrhage, BBB leakage and expression of inflammatory mediators, RAGE, MMP-9 and TLR4. However, tPA treatment in T1DM-MCAo rats (T1DM-MCAo+tPA) significantly enlarged brain hemorrhage, augmented BBB leakage, and failed to decrease lesion volume and improve functional outcome after stroke compared to T1DM-MCAo control. tPA treatment also significantly increased the expression of RAGE, MMP-9 and TLR4 in the ischemic brain in T1DM-MCAo rats compared with T1DM-MCAo control rats (p<0.05). Brain hemorrhage was significantly correlated with functional deficit and RAGE and TLR4 expression, respectively. CONCLUSIONS: Treatment of stroke with tPA increased brain hemorrhage, BBB leakage and failed to improve functional outcome in T1DM rats. The increased inflammatory response may contribute to the failed neuroprotective effects of tPA treatment in T1DM rats.
Authors: Jianhua Qiu; Jian Xu; Yi Zheng; Ying Wei; Xiaoxia Zhu; Eng H Lo; Michael A Moskowitz; John R Sims Journal: Stroke Date: 2010-07-29 Impact factor: 7.914
Authors: J Putaala; R Liebkind; D Gordin; L M Thorn; E Haapaniemi; C Forsblom; P-H Groop; M Kaste; T Tatlisumak Journal: Neurology Date: 2011-05-24 Impact factor: 9.910
Authors: Benjamin G Hassid; M Nathan Nair; Andrew F Ducruet; Marc L Otten; Ricardo J Komotar; David J Pinsky; Ann Marie Schmidt; Shi Fang Yan; E Sander Connolly Journal: J Clin Neurosci Date: 2008-12-13 Impact factor: 1.961
Authors: Weiguo Li; Rebecca Ward; John Paul Valenzuela; Guangkuo Dong; Susan C Fagan; Adviye Ergul Journal: Transl Stroke Res Date: 2017-03-01 Impact factor: 6.829
Authors: Manuel Navarro-Oviedo; Carmen Roncal; Agustina Salicio; Miriam Belzunce; Obdulia Rabal; Estefanía Toledo; Beatriz Zandio; Jose A Rodríguez; Jose A Páramo; Roberto Muñoz; Josune Orbe Journal: Transl Stroke Res Date: 2018-07-27 Impact factor: 6.829
Authors: Yasir Abdul; Mohammed Abdelsaid; Weiguo Li; R Clinton Webb; Jennifer C Sullivan; Guangkuo Dong; Adviye Ergul Journal: Mol Neurobiol Date: 2018-06-16 Impact factor: 5.590